Final Premium Payment Issue Attorneys Willing to Assist Registered Claimants with a Disease Claim Appeals to the 6th Circuit Canadian Settlement Information Claim Submission Issues Claim Forms - SF-DCT Claimant Confidentiality Claimant Information Guide & Questions & Answers Claimants' Advisory Committee Claim Data Totals Class 9, 10.1 and 10.2 Closing Info for SF-DCT Contact Us Court Orders Deadlines Disease Claim Guidelines Late Claims Lien Issues Links to Related Websites MDL 926 Claims Office - Revised Settlement Program MDL 926 Orders Motions in this Case Newsletters - CAC Notice of Intent, Rule 3005 Issues Opt-Out Information for Litigation Other Downloads / Forms Plan Documents (Final) Premium Payment Issue Product Identification SF-DCT Claims Assistance Program SF-DCT Newsletters SF-DCT Processing Timelines Translations Return Home	UPDATED October 27, 2009 REVISED SETTLEMENT IMPLANT LIST OF ELIGIBLE PRODUCTS UPDATED September 10, 2008 The MDL-926 Claims Office has begun mailing letters to attorneys and doctors about the conclusion of the Revised Settlement Program on December 15, 2010. To download or view a copy of the MDL-926 letter and form to attorneys, click HERE. To download a copy of the MDL-926 letter to doctors, click HERE. ORDER APPROVING AFFIDAVIT OF HEIRSHIP AFFIDAVIT OF HEIRSHIP INDEMNITY AGREEMENT For new Q&A's issued by the MDL 926 Claims Office in the Revised Settlement Program, please visit their website at www.claimsoffice-926.com. Recently, the MDL 926 Claims Office solicited comments to proposed Q&A's on Fixed Benefit Claims (Option 1 in the Dow Corning Settlement Option). In response, the CAC submitted a letter with comments. To read the letter, click HERE. The Revised Settlement Program (RSP) was approved by MDL 926 Judge Sam Pointer on December 22, 1995. The RSP is a "claims-made" settlement program that was offered to certain U.S. breast implant recipients with at least one implant from Bristol, Baxter or 3M (or, under certain conditions, a post 8/84 McGhan implant). Dow Corning did not participate in the Revised Settlement Program because it had filed for bankruptcy protection in May 1995. The MDL 926 Claims Office in Houston, Texas is responsible for implementing the RSP and processing claims for Bristol, Baxter, 3M and McGhan. Notice of the RSP and claim forms for that settlement program were mailed in January 1996, and claims in the RSP have been and are still currently being processed and paid. It is important to note that registration in the MDL settlement is not the same as registration of a Proof of Claim form in the Dow Corning bankruptcy case. Claimants must have registered for each settlement separately. The following deadlines and benefits are still currently available in the RSP for claimants who have an eligible implant from either Bristol, Baxter or 3M: Settlement Benefit Deadline in RSP Long-Term Benefit Disease Schedule (this is the same as Disease Option 2 in the Settlement Option in the Dow Corning Trust) December 15, 2010 Explantation for removal of a Bristol, Baxter or 3M breast implant December 15, 2010 Rupture claims - no rupture claims are allowed except for "Current Disease Claimants" Late Registration - claimants who did not file a Timely claim in the RSP may still register with the MDL 926 Claims Office. Late Registrants will be paid benefits only pursuant to the Long Term Disease Schedule to the extent funds are available pursuant to the funding obligations of Bristol, Baxter and 3M. Post 8/84 McGhan Claimants - are eligible to apply only for Long Term Disease. No explant or rupture claims will be paid.   © 2018 Claimants' Advisory Committee. All Rights Reserved.